|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 655 15th Street, NW |
Address2 | Suite 500 |
| City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1262-12
|
||||||||
|
6. House ID# 305260000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Robert Egge |
Date | 4/20/2026 3:47:03 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
NAPA Reauthorization Act (P.L. 118-92)
Alzheimers Accountability and Investment Act (P.L. 118-93)
Comprehensive Care for Alzheimers Act (S. 626 / H.R. 1637 118th Congress)
Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406)
BOLD Reauthorization Act (P.L. 118-142)
Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036)
The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210)
VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress)
Access to Innovative Treatments Act of 2023 (H.R. 2408 118th Congress)
Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress)
Elder Justice Reauthorization and Modernization Act of 2023 (S. 1198/H.R. 2718 118th Congress)
Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress)
Palliative Care and Hospice Education and Training Act (S. 2287/H.R. 4425 119th Congress)
Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress)
Supporting Our Seniors Act (S. 2584 118th Congress)
Alleviating Barriers for Caregiving Act (S. 3109 118th Congress)
Credit for Caring Act of 2025 (S. 925/H.R. 2036)
Lifespan Respite Care Reauthorization Act (S.830/H.R.2560)
DeOndra Dixon Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) Project Act of 2025 (H.R. 3491/S. 1838)
Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996)
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 (S. 2016/H.R. 4189 118th Congress; S. 1261/H.R. 4206 119th Congress)
PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress)
Improving Seniors' Timely Access to Care Act of 2025 (S. 1816/H.R. 3514 119th Congress)
Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act of 2026 (H.R. 7779 119th Congress)
Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092)
Essential Caregivers Act (H.R. 6766 119th Congress)
Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343 119th Congress)
The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269)
Linking Seniors to Needed Legal Services Act (H.R. 8588, 118th Congress)
Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1029)
Catching Up Family Caregivers Act (S. 5149 / H.R. 9764, 118th Congress)
Improving Retirement Security for Family Caregivers Act (S. 5148 / H.R. 9765, 118th Congress)
Charitable Act (S. 317/H.R. 801)
Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389)
Health Tech Investment Act (S.1399)
One Big Beautiful Bill Act (H.R. 1)
Older Americans Act Reauthorization Act of 2025 (S. 2120)
Lowering Costs for Caregivers Act of 2025 (S. 1565 / H.R. 138)
Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269)
Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267)
Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
Other matters related to care payment models, including the GUIDE model
Other matters related to Medicare care planning code 99483
Other matters related to health care workforce shortages
Other matters related to home- and community-based services
Other matters related to disaster preparedness and older adults
Other matters related to Social Security
Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO)
Other matters related to beta-amyloid PET scans
Other matters related to selected diagnoses and services rendered under ICD-10
Other matters related to caregiving
Other matters related to medical devices
Other matters related to rural health
Other matters related to veterans' health and traumatic brain injury (TBI)
Other matters related to Tricare
Other matters related to research
Other matters related to biomarkers including blood based tests and cerebral spinal fluid (CSF)
Other matters related to public health
Other matters related to elder justice, abuse and neglect
Other matters related to Medicaid
Other matters related to nonprofit infrastructure and operations
Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council
Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act
Other matters related to brain health, risk reduction, and the U.S. POINTER study and results
Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS)
Other matters related to long-term care
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Federal Emergency Management Agency (FEMA), Social Security Administration (SSA), Government Accountability Office (GAO), Health Resources & Services Administration (HRSA), Food & Drug Administration (FDA), Indian Health Service, Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Jennifer |
Pollack |
|
|
|
Laura |
Thornhill |
|
|
|
Amy |
Heath |
|
|
|
Mary |
Germiller |
|
|
|
Sarah |
Osuna |
|
|
|
Zoe |
Salzberg |
|
|
|
Jenny |
Harper |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service
Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services
Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease
Other matters related to beta-amyloid PET scans
Other matters related to diagnostics for Alzheimers disease and other dementia
Other matters related to brain health and risk reduction
Other matters related to clinical trials
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Laura |
Thornhill |
|
|
|
Jennifer |
Pollack |
|
|
|
Mary |
Germiller |
|
|
|
Sarah |
Osuna |
|
|
|
Zoe |
Salzberg |
|
|
|
Jenny |
Harper |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |